The store will not work correctly when cookies are disabled.
(3R,4S,5R,6R)-6-(acetoxymethyl)-3-fluorotetrahydro-2H-pyran-2,4,5-triyl triacetate
ID: ALA4214876
Cas Number: 31077-89-1
PubChem CID: 11688873
Max Phase: Preclinical
Molecular Formula: C14H19FO9
Molecular Weight: 350.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)OC[C@H]1OC(OC(C)=O)[C@H](F)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
Standard InChI: InChI=1S/C14H19FO9/c1-6(16)20-5-10-12(21-7(2)17)13(22-8(3)18)11(15)14(24-10)23-9(4)19/h10-14H,5H2,1-4H3/t10-,11-,12-,13-,14?/m1/s1
Standard InChI Key: KIPRSJXOVDEYLX-GNMOMJPPSA-N
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
6.8718 -8.8818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8718 -9.6990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5771 -10.1035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2824 -9.6990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2824 -8.8818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5771 -8.4691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1629 -8.4753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1605 -7.6581 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1647 -10.1086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5771 -10.9206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9895 -10.1086 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.9913 -8.4753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4516 -7.2516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4492 -6.4344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7451 -7.6622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4564 -9.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7493 -10.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4552 -8.8839 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8694 -11.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8694 -12.1464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1617 -10.9206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6978 -8.8859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4067 -8.4794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6954 -9.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 1
7 8 1 0
2 9 1 6
3 10 1 1
4 11 1 6
5 12 1 0
8 13 1 0
13 14 2 0
13 15 1 0
9 16 1 0
16 17 1 0
16 18 2 0
10 19 1 0
19 20 1 0
19 21 2 0
12 22 1 0
22 23 1 0
22 24 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.30 | Molecular Weight (Monoisotopic): 350.1013 | AlogP: 0.04 | #Rotatable Bonds: 5 |
Polar Surface Area: 114.43 | Molecular Species: NEUTRAL | HBA: 9 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -0.28 | CX LogD: -0.28 |
Aromatic Rings: ┄ | Heavy Atoms: 24 | QED Weighted: 0.50 | Np Likeness Score: 1.38 |
References
1. El Hilali M, Reux B, Debiton E, Leal F, Galmier MJ, Vivier M, Chezal JM, Miot-Noirault E, Coudert P, Weber V.. (2017) Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy., 25 (20): [PMID:28927903] [10.1016/j.bmc.2017.08.043] |